Why the study?
Does fenoldopam improve cardiovascular and renal hemodynamics in patients with hypertension or congestive heart failure?
Population
Animal models, hypertensive patients, and patients with congestive heart failure
Design
Review
Authors
Loading...
May support evaluation in hypertension and heart failure; leaves open clinical adoption pending randomized trials.
Does fenoldopam improve cardiovascular and renal hemodynamics in patients with hypertension or congestive heart failure?
Fenoldopam, a selective DA-1 receptor agonist, shows potential as a therapeutic agent for hypertension and heart failure by improving hemodynamics and renal function, though it increases heart rate and renin release.
Mustafa F. Lokhandwala (1987) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: